European Urology

Viewing slides 1-6 of 8

• S0302-2838(11)01441-2.title drag remove slide sort drag into slide Title Botulinum toxin A versus placebo for refractory detrusor overactivity in women: a randomised, blinded, placebo controlled trial of 240 women (the RELAX study) Botulinum toxin A versus placebo for refractory detrusor overactivity in women: a randomised, ... Zoom
• S0302-2838(11)01441-2.introduction drag remove slide sort drag into slide Introduction • Botulinum toxin A (BoNT-A) has been rapidly adopted as a treatment for detrusor overactivity (DO) and overactive bladder (OAB). Although it is now widely available, the evidence in support is ... • Botulinum toxin A (BoNT-A) has been rapidly adopted as a treatment for detrusor overactivity ... Zoom
• 20276 drag remove slide sort drag into slide Consolidated Standards of Reporting Trials diagram.DO = detrusor ... Zoom read this article »
• 20278 drag remove slide sort drag into slide Outcome data at 6 mo.onaBoNTA = botulinum toxin A. Zoom read this article »
• 20280 drag remove slide sort drag into slide Time to patient-reported recurrence of ... Zoom read this article »
• S0302-2838(11)01441-2.materials_and_methods drag remove slide sort drag into slide Materials and methods • 240 women with refractory detrusor overactivity randomized to receive a single treatment with 200 iu onabotulinum toxin A (onaBONT-A) or placebo and followed up for six months
  
  • ... • 240 women with refractory detrusor overactivity randomized to receive a single treatment ... Zoom

Viewing slides 1-6 of 8